The Impact of Moderate to Severe Renal Insufficiency on Patients With Acute Myocardial Infarction

Article (PDF Available)inKorean Circulation Journal 41(6):308-12 · June 2011with23 Reads
DOI: 10.4070/kcj.2011.41.6.308 · Source: PubMed
Abstract
Renal insufficiency (RI) has been reported to be associated with unfavorable clinical outcomes in patients undergoing percutaneous coronary interventions (PCI). However, little data is available regarding the impact of moderate to severe RI on clinical outcomes in patients with acute myocardial infarction (AMI) undergoing PCI. Between March 2003 and July 2007, 878 patients with AMI who underwent PCI were enrolled. Based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation, patients were divided into two groups: eGFR <60 mL/min·m(2) (moderate to severe RI, group A) and eGFR ≥60 mL/min·m(2) (normal to mild RI, group B). The primary endpoint was all-cause mortality at 1-year after successful PCI. The secondary endpoints were non-fatal myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), stent thrombosis (ST) and major adverse cardiac events (MACE) at 1-year. In group A, patients were more often male and older, with diabetes and hypertension. Compared to patients in group B, group A showed significantly higher incidences of all-cause mortality, cardiac mortality, non-fatal MI and MACE. The needs of TLR and TVR, and the incidence of ST were not significantly different between the two groups. Independent predictors of 1-year mortality were eGFR <60 mL/min·m(2), male gender, older age and a lower left ventricular ejection fraction. In patients with AMI, moderate to severe RI was associated with mortality and MACE at 1-year after successful PCI. In addition, eGFR <60 mL/min·m(2) was a strong independent predictor of 1-year mortality.

Full-text (PDF)

Available from: PubMed Central · License: CC BY-NC
  • [Show abstract] [Hide abstract] ABSTRACT: Aim: To study renal dysfunction in patients with myocardial infarction (MI). Subjects and methods: 670 case histories of patients diagnosed with acute coronary syndrome, including 369 (55.8%) men and 292 (44.2%) women at the age of 33 to 85 years (mean age 64.8 +/- 11.7 years), were retrospectively studied. The authors considered comorbidities and analyzed complaints, history data, and the results of physical examinations, biochemical blood tests for plasma glucose, troponin, MB fractions of creatine phosphokinase and creatinine, and cholesterol in all the patients. Instrumental studies involved electro- and echocardiography. Glomerular filtration rate (GFR) was estimated using the MDRD formula. The patients were divided into groups according to GFR values: 1) > 90 ml/min/1.73 m2; 2) 60 to 89 ml/min/1.73 m2; 3) 30 to 59 ml/min/1.73 m2; 4) less than 30 ml/min/1.73 m2. Results: Most patients were found to have a moderate or significant reduction in kidney function. Worsening renal function in patients with MI was associated with advanced patient age, the lower proportion of men in the patient structure, the higher prevalence of concomitant cardiovascular diseases, such as arterial hypertension, chronic heart failure, and prior MI, and diabetes mellitus. Conclusion: The findings suggest that kidney dysfunction is of essential value in developing the multiplicity of comorbidities in patients with MI. The wide introduction of a GFR calculating method in daily medical practice will be able to adequately and timely identify renal filtration function and to make a correction into a treatment regimen, thus decreasing the number of poor outcomes.
    Article · Jul 2013
  • [Show abstract] [Hide abstract] ABSTRACT: Introduction: Risk stratification is important for the management of patients with STEMI. Several studies have been carried out to identify high-risk patients. The aim of this study was to assess the value of admission blood glucose and eGFR for determining long-term prognosis in patients with STEMI undergoing PPCI. Methods: 121 consecutive ST-segment elevation myocardial infarction (STEMI) patients undergoing primary PCI with onset of symptoms within 12 hours were enrolled in the study. Patients were categorized into 3 groups depending on the presence of acute hyperglycemia and impaired renal function. Group I had neither hyperglycemia nor renal dysfunction, group II had renal dysfunction or acute hyperglycemia and whereas group III had both hyperglycemia and impaired renal function. Patients were followed for at least one year for composite cardiovascular end-points, including cardiovascular death, myocardial infarction and stent thrombosis. Results: Major events occurred in 18 (14.9%) of the 121 patients. The incidence of events increased from group 1 to group 3 (9.3% (7) - %14.3 (5) - 54.5% (6), p<0.001). After adjustment for other clinical factors, combined presence of hyperglycemia and renal dysfunction remained an independent predictor for long-term adverse events (HR= 12.50, 95% confidence interval [CI] 2.495 to 24.233, p<0.001). Conclusion: In conclusion, combined use of admission hyperglycemia and eGFR had a significant distinctive capacity for predicting one-year clinical outcome in patients with STEMI undergoing primary PCI.
    Article · Jan 2014 · Terapevticheskii arkhiv